Patient-centered, self-funding dose optimization trials as a route to reduce toxicity, lower cost, and improve access to cancer therapy

I. F. Tannock, Gauthier Bouche, Daniel A. Goldstein, Yasushi Goto, Allen S. Lichter, Kumar Prabhash, Priya Ranganathan, Leonard B. Saltz, Gabe S. Sonke, Garth W. Strohbehn, Roger von Moos, MJ Ratain